RFHIC and MaxLinear Achieve Breakthrough Linearization Performance for Ultra-Wideband 5G New Radio

4 years ago

MaxLinear transceivers and linearization technology combine with RFHIC�s power amplifiers to exceed 3GPP requirements for 5G New Radio (NR) CARLSBAD,…

RFHIC and MaxLinear Achieve Breakthrough Linearization Performance for Ultra-Wideband 5G New Radio

4 years ago

MaxLinear transceivers and linearization technology combine with RFHIC�s power amplifiers to exceed 3GPP requirements for 5G New Radio (NR) CARLSBAD,…

RFHIC and MaxLinear Achieve Breakthrough Linearization Performance for Ultra-Wideband 5G New Radio

4 years ago

MaxLinear transceivers and linearization technology combine with RFHIC�s power amplifiers to exceed 3GPP requirements for 5G New Radio (NR) CARLSBAD,…

Mylab and US-based Hemex Health Announce Technology Partnership for Point-of-Care Diagnostics for COVID-19 and Other Diseases

4 years ago

PUNE, India & PORTLAND, Ore.--(BUSINESS WIRE)--Mylab Discovery Solutions, India�s leading biotechnology company, has joined forces with the United States-based Hemex…

4 years ago

Leading Australian healthcare provider transitions staff to working from home, rolls out Telehealth services to address new realities of patient…

4 years ago

Leading Australian healthcare provider transitions staff to working from home, rolls out Telehealth services to address new realities of patient…

INNIO Joins United Nations Global Compact Further Underscoring Commitment to Sustainability

4 years ago

INNIO joins more than 9,500 companies and 3,000 non-business signatories to support UN goals and issues INNIO joins United Nations…

INNIO Joins United Nations Global Compact Further Underscoring Commitment to Sustainability

4 years ago

INNIO joins more than 9,500 companies and 3,000 non-business signatories to support UN goals and issues INNIO joins United Nations…

4 years ago

Enrollment in the REVERSE-IT global Phase 3 trial from clinical sites in China expected to begin later in 2021 MALVERN,…

4 years ago

Enrollment in the REVERSE-IT global Phase 3 trial from clinical sites in China expected to begin later in 2021 MALVERN,…

Show more Posts
Show previous Posts